Share Your Listing on Social Media to Increase Visibility

Report Abuse

0 0 Reviews

Chimeric Antigen Receptor (CAR) Macrophage Cell Therapy


We have developed an innovative and proprietary platform for next-generation CAR-engineered cell therapies (CAR macrophage therapies) with great therapeutic potential for solid tumor (see Fig.3). Our unique and proprietary CAR-MA platform is utilized to manufacture CAR-MA therapies for a wide range of cancers, especially intractable solid tumors. Given to the special characteristics of macrophages, our approach is to use the macrophages isolated from the blood or THP1 macrophage model, and genetically engineer them to express a CAR to guide them to eat the malignant cells. Once CAR-MA preparation is completed, both in vitro assays and in vivo animal testing will be performed to evaluate the efficacy and safety aspects


Author Info


Member since 9 months ago
View Profile

Contact Listings Owner Form

Chimeric Antigen Receptor (CAR) Macrophage Cell Therapy 0 reviews

Login to Write Your Review

There are no reviews yet.